Micropatterned Co-Cultures of Human Hepatocytes and Stromal Cells for the Assessment of Drug Clearance and Drug-Drug Interactions

Overview

Journal Curr Protoc Toxicol

Specialty Toxicology

Date 2017 May 3

PMID 28463419

Citations 10

Authors

Christine Lin

Salman R Khetani

Affiliations

Soon will be listed here.

Abstract

Drug clearance rates from the body can determine drug exposure that can affect efficacy or toxicity. Thus, accurate prediction of drug clearance during preclinical development can help guide dose selection in humans, but animal testing is not always predictive of human outcomes. Because hepatic drug metabolism is a rate-limiting step in the overall clearance of many drugs, primary human hepatocytes (PHHs) in suspension cultures or monolayers are used for drug clearance predictions. Yet, the precipitous decline in drug metabolism capacity can lead to significant underestimation of clearance rates, particularly for low turnover compounds that have desirable one-pill-a-day dosing regimens. In contrast, micropatterned co-cultures (MPCCs) of PHHs and fibroblasts display phenotypic stability for several weeks and can help mitigate the limitations of conventional cultures. Here, we describe protocols to create and use MPCCs for drug clearance predictions, and for modeling clinically-relevant drug-drug interactions that can affect drug clearance. © 2017 by John Wiley & Sons, Inc.

Citing Articles

Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques.

Guo K, van den Beucken T Cell Biosci. 2024; 14(1):134.

PMID: 39488681 PMC: 11531151. DOI: 10.1186/s13578-024-01317-2.

Pharmacokinetics-Pharmacodynamics Modeling for Evaluating Drug-Drug Interactions in Polypharmacy: Development and Challenges.

Zhao D, Huang P, Yu L, He Y Clin Pharmacokinet. 2024; 63(7):919-944.

PMID: 38888813 DOI: 10.1007/s40262-024-01391-2.

LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer.

Qiao G, Kone L, Phillips E, Lee S, Brown G, Khetani S Oncogene. 2022; 41(14):2054-2068.

PMID: 35177811 PMC: 8975745. DOI: 10.1038/s41388-022-02209-w.

Co-culture with mouse embryonic fibroblasts improves maintenance of metabolic function of human small hepatocyte progenitor cells.

Sengupta S, Johnson B, Seirup M, Ardalani H, Duffin B, Barrett-Wilt G Curr Res Toxicol. 2021; 1:70-84.

PMID: 34345838 PMC: 8320630. DOI: 10.1016/j.crtox.2020.08.001.

Simple, Affordable, and Modular Patterning of Cells using DNA.

Cabral K, Patterson D, Scheideler O, Cole R, Abate A, Schaffer D J Vis Exp. 2021; (168).

PMID: 33720126 PMC: 10870346. DOI: 10.3791/61937.

References

Guguen-Guillouzo C, Clement B, Baffet G, Beaumont C, Glaise D, Guillouzo A . Maintenance and reversibility of active albumin secretion by adult rat hepatocytes co-cultured with another liver epithelial cell type. Exp Cell Res. 1983; 143(1):47-54. DOI: 10.1016/0014-4827(83)90107-6. View

Baudoin R, Legendre A, Jacques S, Cotton J, Bois F, Leclerc E . Evaluation of a liver microfluidic biochip to predict in vivo clearances of seven drugs in rats. J Pharm Sci. 2013; 103(2):706-18. DOI: 10.1002/jps.23796. View

LeCluyse E . Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci. 2001; 13(4):343-68. DOI: 10.1016/s0928-0987(01)00135-x. View

Ploss A, Khetani S, Jones C, Syder A, Trehan K, Gaysinskaya V . Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A. 2010; 107(7):3141-5. PMC: 2840339. DOI: 10.1073/pnas.0915130107. View

Nguyen T, Ukairo O, Khetani S, McVay M, Kanchagar C, Seghezzi W . Establishment of a hepatocyte-kupffer cell coculture model for assessment of proinflammatory cytokine effects on metabolizing enzymes and drug transporters. Drug Metab Dispos. 2015; 43(5):774-85. DOI: 10.1124/dmd.114.061317. View

Khetani S, Chen A, Ranscht B, Bhatia S . T-cadherin modulates hepatocyte functions in vitro. FASEB J. 2008; 22(11):3768-75. PMC: 2574031. DOI: 10.1096/fj.07-105155. View

Davidson M, Lehrer M, Khetani S . Hormone and Drug-Mediated Modulation of Glucose Metabolism in a Microscale Model of the Human Liver. Tissue Eng Part C Methods. 2014; 21(7):716-25. PMC: 4499785. DOI: 10.1089/ten.TEC.2014.0512. View

Atkinson Jr A, Kushner W . Clinical pharmacokinetics. Annu Rev Pharmacol Toxicol. 1979; 19:105-27. DOI: 10.1146/annurev.pa.19.040179.000541. View

Chan T, Yu H, Moore A, Khetani S, Kehtani S, Tweedie D . Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac. Drug Metab Dispos. 2013; 41(12):2024-32. DOI: 10.1124/dmd.113.053397. View

10.

Shlomai A, Schwartz R, Ramanan V, Bhatta A, de Jong Y, Bhatia S . Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems. Proc Natl Acad Sci U S A. 2014; 111(33):12193-8. PMC: 4143014. DOI: 10.1073/pnas.1412631111. View

11.

Wang W, Khetani S, Krzyzewski S, Duignan D, Obach R . Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites. Drug Metab Dispos. 2010; 38(10):1900-5. DOI: 10.1124/dmd.110.034876. View

12.

March S, Ng S, Velmurugan S, Galstian A, Shan J, Logan D . A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe. 2013; 14(1):104-15. PMC: 3780791. DOI: 10.1016/j.chom.2013.06.005. View

13.

Akabane T, Gerst N, Naritomi Y, Masters J, Tamura K . A practical and direct comparison of intrinsic metabolic clearance of several non-CYP enzyme substrates in freshly isolated and cryopreserved hepatocytes. Drug Metab Pharmacokinet. 2011; 27(2):181-91. DOI: 10.2133/dmpk.dmpk-11-rg-097. View

14.

Nishimura M, Ueda N, Naito S . Effects of dimethyl sulfoxide on the gene induction of cytochrome P450 isoforms, UGT-dependent glucuronosyl transferase isoforms, and ABCB1 in primary culture of human hepatocytes. Biol Pharm Bull. 2003; 26(7):1052-6. DOI: 10.1248/bpb.26.1052. View

15.

Peng C, Doshi U, Prakash C, Li A . A Novel Plated Hepatocyte Relay Assay (PHRA) for In Vitro Evaluation of Hepatic Metabolic Clearance of Slowly Metabolized Compounds. Drug Metab Lett. 2015; 10(1):3-15. DOI: 10.2174/1872312809666150818111500. View

16.

Khetani S, Kanchagar C, Ukairo O, Krzyzewski S, Moore A, Shi J . Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans. Toxicol Sci. 2012; 132(1):107-17. DOI: 10.1093/toxsci/kfs326. View

17.

Godoy P, Hewitt N, Albrecht U, Andersen M, Ansari N, Bhattacharya S . Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol. 2013; 87(8):1315-530. PMC: 3753504. DOI: 10.1007/s00204-013-1078-5. View

18.

Davidson M, Ballinger K, Khetani S . Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes. Sci Rep. 2016; 6:28178. PMC: 4911593. DOI: 10.1038/srep28178. View

19.

Hallifax D, Foster J, Houston J . Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view. Pharm Res. 2010; 27(10):2150-61. DOI: 10.1007/s11095-010-0218-3. View

20.

Di L, Trapa P, Obach R, Atkinson K, Bi Y, Wolford A . A novel relay method for determining low-clearance values. Drug Metab Dispos. 2012; 40(9):1860-5. DOI: 10.1124/dmd.112.046425. View